Table 2.
Univariate and multivariate analyses of potential prognostic factors associated with the overall survival of 42 SCLC patients
| Univariate analysis | Multivariate analysis | |||||
|---|---|---|---|---|---|---|
|
|
|
|||||
| Variables | Hazard ratio | 95% CI | P value | Hazard ratio | 95% CI | P value |
| Gender | 0.730 | 0.258-2.059 | 0.551 | 1.807 | 0.521-6.275 | 0.351 |
| Age, y | 1.154 | 0.379-3.517 | 0.800 | 1.656 | 0.485-5.656 | 0.421 |
| Disease stage | 19.574 | 4.318-88.731 | 0.000 | 29.344 | 3.897-220.936 | 0.001 |
| Drug-sensitivity | 6.858 | 2.658-17.700 | 0.000 | 4.240 | 1.079-16.657 | 0.038 |
| MYCN expression | 0.104 | 0.038-0.284 | 0.000 | 0.062 | 0.013-0.282 | 0.000 |
CI, confidence interval; The P-value was calculated by Cox proportional hazards model.